Figure 2From: Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials Risk Ratio for response of SSRIs vs Placebo in Parkinson's Disease Patients.Back to article page